HON CORP(08259.HK)接獲額外恢復買賣指引
格隆匯1月4日丨HON CORP(08259.HK)公吿,除初步恢復買賣指引外,公司於2021年12月29日接獲聯交所函件,據此,聯交所對恢復公司股份買賣施加以下額外恢復買賣指引:(i)展示公司具備可有效負責管理及經營公司的董事會,及充足的財務申報及其他程序及系統,以符合GEM上市規則項下所有持續責任;及(ii)重新符合GEM上市規則第5.05、5.19、5.24、5.28及5.34條。
聯交所進一步表示,如情況有變,其或會修改恢復買賣指引及給予進一步指引。
截至公吿日期,集團繼續積極尋求在中國"大健康"業務潛在合作方面的新潛在商機,務求拓寬其收入來源及將公司股東的回報最大化。
繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.